IMC Retains Expression Analysis, Inc. For Affymetrix GeneChip(R) Processing Services For The National Institutes Of Drug Abuse Clinical Trial Contract

DURHAM, N.C.--(BUSINESS WIRE)--June 8, 2006--Expression Analysis, Inc., a full-service microarray processing, analysis and data management organization, has entered into an agreement with IMC, an award-winning solutions company, to provide isolation of genomic samples and Affymetrix microarray processing for samples from a clinical trial IMC is conducting on an award from the National Institute on Drug Abuse.

MORE ON THIS TOPIC